Kestra Medical (KMTS) CEO Brian Webster Sells 51,900 Shares

What Happened
Brian Daniel Webster, President and Chief Executive Officer of Kestra Medical Technologies, sold a total of 51,900 shares in open-market transactions on August 4, 2026. The sales break down as: 48,625 shares at a weighted average price of $24.47 for $1,189,815; 2,833 shares at $25.16 for $71,288; and 442 shares at $25.98 for $11,485 — total proceeds approximately $1,272,588. These were sales (S) reported as nondiscretionary sell-to-cover transactions to satisfy tax withholding on vested restricted stock units (RSUs).

Key Details

• Transaction date: August 4, 2026; Form 4 filed August 6, 2026 (timely filing).
• Lot price details (weighted averages reported): $24.47, $25.16, $25.98. Footnotes report actual sale-price ranges of $23.90–$24.885, $24.95–$25.93, and $25.95–$26.03 for the respective lots.
• Reason: F1 indicates nondiscretionary sell-to-cover to satisfy tax withholding related to RSU vesting.
• Shares owned after the transaction: not specified in the provided filing data.
• Transaction codes: S = Sale; F (tax withholding) applies here.

Context
Sell-to-cover transactions tied to RSU vesting are routine tax-related dispositions and do not necessarily reflect the insider’s view of the company. This was not an option exercise or a gift — it was a tax-withholding sale of vested shares.